Table 1.
Target gene (HUGO nomenclature) | Primers (5′-3′) | Fragment size/bp |
---|---|---|
RUNX2 |
F: CCTCCTACCTGAGCCAGATG R: ATGAAATGCTTGGGAACTGC |
165 |
ALP (ALPL) |
F: ACCATTCCCACGTCTTCACATTTG R: AGACATTCTCTCGTTCACCGCC |
162 |
COL1 (COL1A1) |
F: AGGGACACAGAGGTTTCAGT R: AGCACCATCATTTCCACGAG |
188 |
PHEX |
F: TATCTTGAAGCTGGACCAAGCA R: ACTTGTAAAGGGCATCCCGA |
101 |
MEPE |
F: GGGCCTGCCCATTCCTTCTCGT R: ACCCCAGGAGCCTTTCCCTTGTG |
178 |
PSA (KLK3) |
F: AGTGCGAGAAGCATTCCCAAC R: CCAGCAAGATCACGCTTTTGTT |
138 |
AR |
F: CTGGACACGACAACAACCAG R: CAGATCAGGGGCGAAGTAGA |
245 |
BMP1 |
F: CTTCTGGCACGAACACACTCG R: ACTCCTGCCCTGGCTGGAT |
80 |
ON (SPARC) |
F: CAAATACATCCCCCCTTGCC R: GATCTTCTTCACCCGCAGCTT |
151 |
OPG (TNFRSF11B) |
F: TTCCGGAAACAGTGAATCAA R: CGCTGTTTTCACAGAGGTCA |
287 |
FN (FN1) |
F: CAGTGGGAGACCTCGAGAAG R: TCCCTCGGAACATCAGAAAC |
168 |
PTH1R |
F: GCGGAGCTGAGGAGACGTAG R: CTTCCCTGATGTGGACGCAG |
185 |
SOST |
F: AGAGTACCCCGAGCCTCC R: AGCTGTACTCGGACACGTCTTTG |
116 |
IBSP |
F: ACGAACAAGGCATAAACGGCACCA R: CTTGCCCTGCCTTCCGGTCT |
153 |
E11 (PDPN) |
F: TTACTAGCCATCGGCTTCATTG R: GGCGAGTACCTTCCCGACAT |
71 |
RANKL (TNFSF11) |
F: CTCAGCCTTTTGCTCATCTCACT R: CAAGAGGACAGACTCACTTTATGG |
77 |
DDC |
F: CAAGTCACTCCCGGCTGC R: CTCCTTCCCTCTCCTTCGGA |
84 |
ENO2 |
F: GTGCACAGGCCAGATCAAGA R: ACAGCACACTGGGATTACGG |
140 |
RPL32 |
F: GCACCAGTCAGACCGATATG R: ACTGGGCAGCATGTGCTTTG |
151 |
7SL |
F: ATCGGGTGTCCGCACTAAGTT R: CAGCACGGGAGTTTTGACCT |
126 |